June 2008 Indie Next List
“A riveting courtroom drama concerning a patent for an AIDS vaccine, this story illuminates the incompatibility of current patent law and cutting-edge biotechnology. An entertaining and intelligent read.”
— Jeanne Regentin, Between the Covers, Harbor Springs, MI
A gripping inside look at high-stakes lawyering, A Patent Lie is further evidence that Paul Goldstein is an emerging master of the legal thriller.After being forced from his high-powered Manhattan law firm, Michael Seeley--the tough-but-wounded hero of "Errors and Omissions"--has set up shop in his native Buffalo. Partly out of need, partly out of pride, Seeley takes on a case for his estranged brother, whose small biotech firm is suing a Swiss pharmaceutical giant over a controversial new AIDS vaccine. Seeley heads out to Silicon Valley to lead the case, but soon realizes there is much more at stake than he was first led to believe. As certain partnerships come to light, and financial gains become staggeringly clear, Seeley's own life may be in grave danger.
About the Author
Paul Goldstein is the Lillick Professor of Law at Stanford Law School and is widely recognized as one of the country's leading authorities on intellectual property law. He is regularly included in "The Best Lawyers in America "and testifies before congressional committees and international government meetings on intellectual property issues. "A Patent Lie" is the sequel to his first novel, "Errors and Omissions." A New York native, he now lives outside San Francisco.
“John Grisham made the contemporary legal thriller into a bestselling genre. Goldstein has transformed the genre into an art form.”—Dallas Morning News “Fresh and original.” —Sue Grafton“A complex story, very well told, of a gray and shifting universe in which most things are not what they seem.” —San Jose Mercury News“Smart, challenging. . . . Among the novel's pleasures are [Goldstein's] insights into lawyers and the games they play.” —The Washington Post Book World“Timely and fascinating. . . . Gives readers interested in the drama of a high-value legal case a great reward for their attention.” —Alan Cheuse, NPR's All Things Considered